Bovilis® BVD Suspension for injection for cattle
An inactivated BVD vaccine for cows and heifers to protect the foetus against transplacental infection with bovine viral diarrhoea virus (BVDV). Can be mixed and administered with Bovilis IBR Marker Live, or administered with Bovilis Leptavoid®-H; see Bovilis IBR Marker Live and Bovilis Leptavoid-H datasheets for more information.
Presentation
Suspension for injection
Active ingredients
Each dose of 2 ml contains: Inactivated cytopathogenic bovine viral diarrhoea (BVD) virus type 1 strain C-86, containing 50 ELISA Units (EU) and inducing at least 4.6 log2 VN units*
*Mean virus neutralizing titre obtained in the potency test
Target species
Cattle
Indications for use
For active immunisation of cows and heifers from eight months of age onwards to protect the foetus against transplacental infection with BVDV.
Safety and efficacy data are available which demonstrate that for re-vaccination in cattle from 15 months of age onwards (i.e. those that have previously been vaccinated separately with Bovilis BVD and Bovilis IBR marker live) - this vaccine can be mixed and administered with Bovilis IBR marker live.
Withdrawal periods
Cattle - milk 0 hours, meat 0 days
Packaging
2 ml single dose or 10/20/50/100 or 250 ml multidose vial of glass, hydrolytical class Type I (Ph. Eur.) or polyethylene-terephthalate (PET) closed with a halogenobutyl rubber stopper and sealed with an aluminium cap. Not all pack sizes may be marketed.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: December 2023